Skip to content
Insider tapeFilings through Fri, Oct 2
Watchlist

Jeffrey M Leiden

Chair at Vertex Pharmaceuticals Inc / Ma (VRTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $60.9M

Reported trades

Filed Stock Type Shares Price Value Since
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 4,469 $440.40 $2.0M +14.3%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,320 $441.26 $582K +14.1%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2,469 $443.21 $1.1M +13.6%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 4,352 $444.36 $1.9M +13.3%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 7,899 $445.56 $3.5M +13.0%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,152 $447.05 $515K +12.6%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2,320 $448.78 $1.0M +12.2%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 5,880 $449.84 $2.6M +11.9%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 5,809 $451.20 $2.6M +11.6%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 15,681 $452.20 $7.1M +11.3%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 10,360 $453.34 $4.7M +11.1%
Dec 5SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 2,070 $455.22 $942K +10.6%
Nov 17SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 18,528 $440.22 $8.2M +14.4%
Nov 17SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 1,160 $441.05 $512K +14.2%
Nov 17SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 32,234 $440.30 $14.2M +14.4%
Nov 17SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 21,330 $441.35 $9.4M +14.1%
Nov 17SEC VRTXVertex Pharmaceuticals Inc / Ma Sell Plan 40 $442.00 $18K +13.9%
  • Sell

    Chair Jeffrey M Leiden sold $2.0M of VRTX at $440.40 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chair Jeffrey M Leiden sold $582K of VRTX at $441.26 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chair Jeffrey M Leiden sold $1.1M of VRTX at $443.21 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chair Jeffrey M Leiden sold $1.9M of VRTX at $444.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chair Jeffrey M Leiden sold $3.5M of VRTX at $445.56 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chair Jeffrey M Leiden sold $515K of VRTX at $447.05 — pre-scheduled 10b5-1 plan sale.